Breast Surgery: Clinical Trials

2 trials for Breast Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1
Phase 21Completed 1

Follow Breast Surgery: new trials by email Literature Review of Breast Surgery trials Research Report on Breast Surgery

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority Study of Placebo vs Cefazolin
Cefazolin 2 g Infusion, Placebo infusion of .9 normal saline - Breast Cancer, Breast Surgery
Phase 3Not yet recruitingUniversity Hospital, Clermont-Ferrand16002026-11-012026-10-27
Pilot Trial: Postoperative Opioid-free Analgesia
Opioid analgesics, Non-opioid analgesics - Outpatient Surgery, Abdominal Surgery
Phase 2 / Phase 3CompletedMcGill University Health Centre/Research Institute of the McGill University Health Centre812020-01-292024-11-20

Narrower conditions

Agnosia (1)  ·  Breast Neoplasms (1)  ·  Pain, Postoperative (1)  ·  Surgical Wound Infection (1)

Broader conditions

Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Postoperative Complications (2)  ·  Breast Diseases (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Perceptual Disorders (1)  ·  Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Analgesics, Non-Narcotic (1)  ·  Analgesics, Opioid (1)  ·  Cefazolin (1)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  University Hospital, Clermont-Ferrand (1)

Countries

Canada (1)  ·  France (1)

Top investigators

Marc Garnier, MD, PhD (1)

Results publications

PMID 35849399

NIH funding

2025 (1)